METS-IR与代谢性疾病的研究进展

Research Progress on METS-IR and Metabolic Diseases

代谢性疾病主要包括心血管疾病、糖尿病和非酒精性脂肪性肝病等,近年来已成为重要的公共卫生问题。相关研究证明,胰岛素抵抗(IR)在代谢性疾病发生和发展中有重要作用。胰岛素抵抗代谢评分(METS-IR)是评估IR的简易指标,同时其是常规检测易得到的无创数据。近年来,相关研究表明,METS-IR对冠心病、高血压、冠状动脉钙化、糖尿病、非酒精性脂肪性肝病等有重要预测价值。基于此,本文就METS-IR对代谢性疾病的诊断及临床应用价值进行综述。

Metabolic diseases mainly include cardiovascular diseases,diabetes mellitus and non-alcoholic fatty liver disease,which have become an important public health problems in recent years.Related studies have shown that insulin resistance(IR)plays an important role in the occurrence and progression of metabolic diseases.The metabolic score of insulin resistance(METS-IR)is a simple indicator of IR,and it is also a non-invasive data that can be easily obtained by routine detection.In recent years,related studies have shown that METS-IR has important predictive value in coronary heart disease,hypertension,coronary artery calcium,diabetes mellitus and non-alcoholic fatty liver disease.Based on this,this article reviews the value of METS-IR in the diagnosis and clinical application value of metabolic diseases.